Literature DB >> 21520287

Appetitive motivational deficits in individuals with Parkinson's disease.

Danielle M Shore1, Robert Rafal, John A Parkinson.   

Abstract

Parkinson's disease is known for its effects on sensorimotor coordination caused by degeneration of the nigrostriatal dopamine pathway. Dopamine-innervated areas of the ventral striatum also become compromised in Parkinson's disease, and little is known about the potential impact of this pathology on motivational processes mediated by the mesolimbic dopamine system. The current study tested the hypothesis that patients with Parkinson's disease would show a deficit in appetitive motivational arousal. Patients with Parkinson's disease and age-matched healthy controls completed a visual discrimination task in which control and appetitive food images (incidental to the task) were presented in the background. Response rate changes indicated appetitive motivational arousal. The healthy controls showed an increase in response rate on the task when appetitive food cues were present compared with control stimuli. In contrast, the Parkinson's disease group showed an inverse pattern to the healthy controls. The reduction in appetitive motivation correlated with an individual's Parkinsonian symptomology. Patients with Parkinson's disease demonstrated an impairment in appetitive motivational arousal consistent with the progression of dopaminergic degeneration across the course of the disease. Dysfunction of this system affects quality of life in Parkinson's disease, and a blunting of the anticipatory motivation may contribute to the high prevalence of depression in Parkinson's disease.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21520287     DOI: 10.1002/mds.23736

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

Review 1.  The mysterious motivational functions of mesolimbic dopamine.

Authors:  John D Salamone; Mercè Correa
Journal:  Neuron       Date:  2012-11-08       Impact factor: 17.173

2.  Dopamine on D2-like receptors "reboosts" dopamine D1-like receptor-mediated behavioural activation in rats licking for a isotonic NaCl solution.

Authors:  Adriana Galistu; Paolo S D'Aquila
Journal:  Psychopharmacology (Berl)       Date:  2013-04-30       Impact factor: 4.530

3.  Daily memantine treatment blunts hedonic response to sucrose in rats.

Authors:  Adriana Galistu; Paolo S D'Aquila
Journal:  Psychopharmacology (Berl)       Date:  2019-08-14       Impact factor: 4.530

Review 4.  The neurobiology of anhedonia and other reward-related deficits.

Authors:  Andre Der-Avakian; Athina Markou
Journal:  Trends Neurosci       Date:  2011-12-15       Impact factor: 13.837

Review 5.  Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.

Authors:  John D Salamone; Samantha E Yohn; Laura López-Cruz; Noemí San Miguel; Mercè Correa
Journal:  Brain       Date:  2016-05       Impact factor: 13.501

Review 6.  Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects.

Authors:  Kai Ma; Nian Xiong; Yan Shen; Chao Han; Ling Liu; Guoxin Zhang; Luxi Wang; Shiyi Guo; Xingfang Guo; Yun Xia; Fang Wan; Jinsha Huang; Zhicheng Lin; Tao Wang
Journal:  Front Aging Neurosci       Date:  2018-01-19       Impact factor: 5.750

7.  Defining the unknowns for cell therapies in Parkinson's disease.

Authors:  Emma L Lane; Mariah J Lelos
Journal:  Dis Model Mech       Date:  2022-09-27       Impact factor: 5.732

8.  Reward and punishment: investigating cortico-bulbar excitability to disclose the value of goods.

Authors:  Carmelo M Vicario; Ada Kritikos; Alessio Avenanti; Robert Rafal
Journal:  Front Psychol       Date:  2013-02-05

9.  The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.

Authors:  Patrick A Randall; Christie A Lee; Eric J Nunes; Samantha E Yohn; Victoria Nowak; Bilal Khan; Priya Shah; Saagar Pandit; V Kiran Vemuri; Alex Makriyannis; Younis Baqi; Christa E Müller; Merce Correa; John D Salamone
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.